Boston, Massachusetts
March 8–11, 2020


Conference Dates and Location: 
February 22–25, 2016 | Boston, Massachusetts
Abstract Number: 

Determinants of Economic Efficiency in HIV Prevention: Evidence From ORPHEA Kenya


Omar Galarraga1; Richard Wamai2; Sandra G. Sosa-Rubi3; Mercy Mugo4; David Contreras3; Sergio Bautista-Arredondo3; Helen Nyakundi4; Joseph Wang'Ombe4
1Brown Univ Sch of PH, Providence, RI, USA;2Northeastern Univ, Boston, MA, USA;3INSP, Cuernavaca, Mexico;4Univ of Nairobi, Nairobi, Kenya

Abstract Body: 

We analyze determinants of economic efficiency for three HIV prevention interventions in Kenya: HIV testing & counselling (HTC), prevention of mother-to-child transmission (PMTCT), and male circumcision (MC). As part of the “Optimizing the Response of Prevention: HIV Efficiency in Africa” (ORPHEA) project, input data were collected retrospectively from sample of government and non-governmental health facilities for 2011-12. 

Multi-stage sampling was used to determine the sample of health facilities by type, ownership, size, and interventions offered totaling 175 sites in 78 health facilities in 33 districts across Kenya. Data sources included key informants, registers and time-motion methods. Total costs of production were computed using both quantity and unit price of each input. Average cost was estimated by dividing total cost per intervention by number of clients accessing the intervention. Forward-selection stepwise regression methods were used to identify and analyze significant determinants of log-transformed average costs (p<0.1). 

Results show evidence of economies of scale for all three interventions: doubling the number of clients per year was associated with average cost reductions of 39% for HTC, 49% for PMTCT, and 69% for MC. Moreover, task shifting was associated with reduced costs for both PMTCT (47%) and MC (44%), but not for HTC.  Costs in hospitals were higher for both HTC (56%) and PMTCT (60%) in comparison to non-hospitals, but this was not the case for MC. Performance incentives for staff were associated with increased costs in both HTC (50%) and PMTCT (64%), but not in MC. Facilities that performed community-based testing had higher HTC average costs (49%); and lower MC costs were associated with availability of male reproductive health services (81%) and presence of community advisory board (58%).  

Aside from increasing production scale, HIV prevention costs may be contained by using task shifting, non-hospital sites, service integration and community supervision.  The extant results have implications for HIV prevention programs in Kenya, and sub-Saharan Africa more generally.

Session Number: 
Session Title: 
Modeling the (Cost) Efficiency of Testing and Prevention
Presenting Author: 
Omar Galarraga
Presenter Institution: 
Brown University School of Public Health